| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB100-55744 | |||
| BSA Free | NB100-56618SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF631-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB631-SP | |||
| Carrier Free | MAB631-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF721-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74578 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1540-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB6313-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80067 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-80066 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-24388SS | |||
![Western Blot: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Total protein from HL-60, HepG2, HCT-116 and human placenta was separated on a 12% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-TRAIL R2 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-Western-Blot-NB100-56618-img0005.jpg "Western Blot: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Total protein from HL-60, HepG2, HCT-116 and human placenta was separated on a 12% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-TRAIL R2 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Analysis of a formalin fixed paraffin-embedded (FFPE) human brain cerebellum using 1:200 conc. of TRAIL R2/TNFRSF10B antibody on a Bond Rx autostainer (Leica Biosystems). The assay involved 30 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 9.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 15 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Cytoplasmic staining was observed in the Purkinje cell layer.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-Immunohistochemistry-Paraffin-NB100-56618-img0007.jpg)
![<b>Biological Strategies Validation. </b>Immunohistochemistry: TRAILR2/TNFRSF10B Antibody [NB100-56618] - Pharmacodynamic assays for ONC201. IHC analyses of CHOP, TRAILR2/TNFRSF10B, and double-stranded DNA breaks (TUNEL) in baseline and ONC201-treated biopsies for an endometrial cancer patient. The biopsy was done 9.8 months after starting ONC201 treatment (7 days after the most recent ONC201 dose). Image collected and cropped by CiteAb from the following publication (//jitc.biomedcentral.com/articles/10.1186/s40425-019-0599-8) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/TRAILR2-TNFRSF10B-Antibody-Immunohistochemistry-NB100-56618-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: TRAIL R2/TNFRSF10B Antibody [NB100-56618] - HepG2 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X TBS + 0.5% Triton-X100. The cells were incubated with anti-TRAIL R2 (H76) at 5ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Alpha tubulin (DM1A) NB100-690 was used as a co-stain at a 1:1000 dilution and detected with an anti-mouse Dylight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-Immunocytochemistry-Immunofluorescence-NB100-56618-img0004.jpg)
![Western Blot: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Analysis using the Azide Free version of NB100-56618. Detection of 20 ug of whole cell lysates from HL60 cells with anti-TRAIL-R2 at 5 ug/ml.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-Western-Blot-NB100-56618-img0003.jpg)
![Western Blot: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF10B.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Western-Blot-NBP2-46148-img0009.jpg "Western Blot: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF10B.")
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Carcinoma of Human thyroid tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0008.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0001.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Human tonsil tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0002.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Carcinoma of Human kidney tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0003.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Human lymphoma tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0004.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0005.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0006.jpg)
![Immunohistochemistry: TRAIL R2/TNFRSF10B Antibody (2A5) [NBP2-46148] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-2A5-Immunohistochemistry-NBP2-46148-img0007.jpg)
![Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody (HS201) [NBP2-80066] - Staining of TRAIL-R2 using anti-TRAIL-R2 (human), mAb (HS201) in human liver tissue (15 ug/mL).](http://images.novusbio.com/fullsize/TRAILR2-TNFRSF10B-Antibody-HS201-Immunohistochemistry-Paraffin-NBP2-80066-img0001.jpg "Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody (HS201) [NBP2-80066] - Staining of TRAIL-R2 using anti-TRAIL-R2 (human), mAb (HS201) in human liver tissue (15 ug/mL).")
![Immunohistochemistry: TRAILR2/TNFRSF10B Antibody (HS201) - Azide and BSA Free [NBP2-80067] - Staining of TRAIL-R2 using anti-TRAIL-R2 (human), mAb (HS201) in human liver tissue (15 ug/mL).](http://images.novusbio.com/fullsize/TRAILR2-TNFRSF10B-Antibody-HS201-Azide-and-BSA-Free-Immunohistochemistry-NBP2-80067-img0001.jpg "Immunohistochemistry: TRAILR2/TNFRSF10B Antibody (HS201) - Azide and BSA Free [NBP2-80067] - Staining of TRAIL-R2 using anti-TRAIL-R2 (human), mAb (HS201) in human liver tissue (15 ug/mL).")
![Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody (TR2.21) [NBP2-80070] - Negative control.](http://images.novusbio.com/fullsize/TRAILR2-TNFRSF10B-Antibody-TR2-21-Immunohistochemistry-Paraffin-NBP2-80070-img0002.jpg "Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody (TR2.21) [NBP2-80070] - Negative control.")
![Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody (TR2.21) [NBP2-80070] - Immunohistochemistry detection of endogenous TRAIL-R2 in paraffin-embedded human carcinoma tissues (colon, tonsil) using mAb to TRAIL-R2 (TR2.21).](http://images.novusbio.com/fullsize/TRAILR2-TNFRSF10B-Antibody-TR2-21-Immunohistochemistry-Paraffin-NBP2-80070-img0001.jpg)
![Western Blot: TRAIL R2/TNFRSF10B Antibody [NBP2-24388] - Analysis at 1:500 dilution on 50 ug of transfected 293 T cells.](http://images.novusbio.com/fullsize/TRAIL-R2-TNFRSF10B-Antibody-Western-Blot-NBP2-24388-img0002.jpg "Western Blot: TRAIL R2/TNFRSF10B Antibody [NBP2-24388] - Analysis at 1:500 dilution on 50 ug of transfected 293 T cells.")